Reata Pharmaceuticals Inc

WELLINGTON MANAGEMENT GROUP LLP

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/14/2023

Shares

1,472,043

Value ($000)

150,090

Weight

0.0%

2019 Q4 - 2023 Q2 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/14/2023	150,090	0.0%	1,472,043	6/30/2023
2023 Q1	5/12/2023	129,212	0.0%	1,421,162	3/31/2023
2022 Q4	2/13/2023	57,284	0.0%	1,507,882	12/31/2022
2022 Q3	11/14/2022	39,511	0.0%	1,572,266	9/30/2022
2022 Q2	8/15/2022	121,853	0.0%	4,009,660	6/30/2022
2022 Q1	5/16/2022	144,030	0.0%	4,396,539	3/31/2022
2021 Q4	2/11/2022	112,150	0.0%	4,252,977	12/31/2021
2021 Q3	11/15/2021	426,917	0.1%	4,243,272	9/30/2021
2021 Q2	8/16/2021	612,325	0.1%	4,326,468	6/30/2021
2021 Q1	5/17/2021	434,271	0.1%	4,355,767	3/31/2021
2020 Q4	2/12/2021	537,219	0.1%	4,345,724	12/31/2020
2020 Q3	11/16/2020	388,681	0.1%	3,989,752	9/30/2020
2020 Q2	8/14/2020	583,780	0.1%	3,741,699	6/30/2020
2020 Q1	5/14/2020	436,039	0.1%	3,020,924	3/31/2020
2019 Q4	2/11/2020	489,134	0.1%	2,392,674	12/31/2019